Paracrine activation of the HIV-LTR promoter by the viral Tat protein is mechanistically similar to trans-activation within a cell

Virology

Volumn 225, Issue 2, 1996, Pages 316-327

  Verhoef, Koen ^a   Klein, André ^a   Berkhout, Ben ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN; TRANSACTIVATOR PROTEIN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN TRANSPORT; TRANSCRIPTION REGULATION; VIRUS CELL INTERACTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030588990     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0606     Document Type: Article

References (81)

1. Acland, P., Dixon, M., Peters, G., and Dickson, C. (1990). Subcellular fate of the Int-2 oncoprotein is determined by choice of initiation codon. Nature 343, 662-665.
2. Barillari, G., Gendelman, R., Gallo, R. C., and Ensoli, B. (1993). The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc. Natl. Acad. Sci. USA 90, 7941-7945.
3. Berkhout, B., Silverman, R. H., and Jeang, K. T. (1989). Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell 59, 273-282.
4. Berkhout, B., Gatignol, A., Rabson, A. B., and Jeang, K. T. (1990). TAR-independent activation of the HIV-1 LTR Evidence that tat requires specific regions of the promoter. Cell 62, 757-767.
5. Berkhout, B., and Jeang, K. T. (1989). trans activation of human immunodeficiency virus type 1 is sequence specific for both the single-stranded bulge and loop of the trans-acting-responsive hairpin: A quantitative analysis. J. Virol. 63, 5501-5504.
6. Berkhout, B., and Jeang, K. T. (1991). Detailed mutational analysis of TAR RNA: Critical spacing between the bulge and loop recognition domains. Nucleic Acids Res. 19, 6169-6176.
7. Berkhout, B., and Jeang, K. T. (1992). Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 66, 139-149.
8. Brady, H. J. M., Abraham, D. J., Pennington, D. J., Miles, C. G., Jenkins, S., and Dzierzak, E. A. (1995). Altered cytokine expression in T lymphocytes from human immunodeficiency virus Tat transgenic mice. J. Virol. 69, 7622-7629.
9. Brake, D. A., Debouck, C., and Biesecker, G. (1990a). Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein, tat. J. Cell Biol. 111, 1275-1281.
10. Brake, D. A., Goudsmit, J., Krone, W. J., Schammel, P., Appleby, N., Meloen, R. H., and Debouck, C. (1990b). Characterization of murine monoclonal antibodies to the tat protein from human immunodeficiency virus type 1. J. Virol. 64, 962-965.
11. Buonaguro, L., Barillari, G., Chang, H. K., Bohan, C. A., Kao, V., Morgan, R., Gallo, R. C., and Ensoli, B. (1992). Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. J. Virol. 66, 7159-7167.
12. Buonaguro, L., Buonaguro, F.M., Giraldo, G., and Ensoli, B. (1994). The human immunodeficiency virus type 1 Tat protein transactivates tumor necrosis factor beta gene expression through a TAR-like structure. J. Virol. 68, 2677-2682.
13. Chang, H. K., Gallo, R. C., and Ensoli, B. (1995). Regulation of cellular gene expression and function by the Human Immunodeficiency virus type 1 Tat protein. J. Biomed. Sci. 2, 189-202.
14. Chin, D. J., Selby, M. J., and Peterlin, B. M. (1991). Human immunodeficiency virus type 1 Tat does not transactivate mature trans-acting responsive region RNA species in the nucleus or cytoplasm of primate cells. J. Virol. 65, 1758-1764.
15. Conant, K., Ma, M., Nath, A., and Major, E. O. (1996). Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kB binding and protein kinase C activity in primary human astrocytes. J. Virol. 70, 1384-1389.
16. Cordingley, M. G., LaFemina, R. L., Callahan, P. L., Condra, J. H., Sardana, V. V., Graham, D. J., Nguyen, T. M., LeGrow, K., Gotlib, L., Schlabach, A. J., et al. (1990). Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro. Proc. Natl. Acad. Sci. USA 87, 8985-8989.
17. Cullen, B. R. (1993). Does HIV-1 Tat induce a change in viral initiation rights? Cell 73, 417-420.
18. Cupp, C., Taylor, J. P., Khalili, K., and Amini, S. (1993). Evidence for stimulation of the transforming growth factor beta 1 promoter by HIV-1 Tat in cells derived from CNS. Oncogene 8, 2231-2236.
19. Das, A. T., Klaver, B., and Berkhout, B. (1995). Reduced replication of human immunodeficiency virus type 1 mutants that use reverse transcription primers other than the natural tRNA(3Lys). J. Virol. 69, 3090-3097.
20. Dingwall, C., Ernberg, I., Gait, M. J., Green, S. M., Heaphy, S., Karn, J., Lowe, A. D., Singh, M., Skinner, M. A., and Valerie, R. (1989). Human Immunodeficiency Virus 1 tat protein binds trans-activating-responsive region (TAR) RNA in vitro. Proc. Natl. Acad. Sci. USA 86, 6925-6929.
21. Dingwall, C., Ernberg, I., Gait, M. J., Green, S. M., Heaphy, S., Karn, J., Lowe, A. D., Singh, M., and Skinner, M. A. (1990). HIV-1 tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure. EMBO J. 9, 4145-4153.
22. Ensoli, B., Buonaguro, L., Barillari, G., Fiorelli, V., Gendelman, R., Morgan, R. A., Wingfield, P., and Gallo, R. C. (1993). Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67, 277-287.
23. Fawell, S., Seery, J., Daikh, Y., Moore, C., Chen, L. L., Pepinsky, B., and Barsoum, J. (1994). Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. USA 91, 664-668.
24. Feng, S., and Holland, E. C. (1988). HIV-1 tat trans-activation requires the loop sequence within tar. Nature 334, 165-167.
25. Frankel, A. D., Biancalana, S., and Hudson, D. (1989). Activity of syn thetic peptides from the Tat protein of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86, 7397-7401.
26. Frankel, A. D., and Pabo, C. O. (1988). Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55, 1189-1193.
27. Fridell, R. A., Harding, L. S., Bogerd, H. P., and Cullen, B. R. (1995). Identification of a novel human zinc finger protein that specifically interacts with the activation domain of lentiviral Tat proteins. Virology 209, 347-357.
28. Garcia, J. A., Harrich, D., Soutanakis, E., Wu, F., Mitsuyasu, R., and Gaynor, R. B. (1989). Human immuno defeciency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation. EMBO J. 8, 765-778.
29. Gatignol, A., Buckler-White, A., Berkhout, B., and Jeang, K. T. (1991). Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR Science 251, 1597-1600.
30. Gentz, R., Chen, C.-H., and Rosen, C. A. (1989). Bioassay for trans-activation using purified human immunodeficiency virus tat-encoded protein: Trans-activation requires mRNA synthesis. Proc. Natl. Acad. Sci. USA 86, 821-824.
31. Green, M., and Loewenstein, P. M. (1988). Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 55, 1179-1188.
32. Harrich, D., Garcia, J., Mitsuyasu, R., and Gaynor, R. (1990). TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes. EMBO J. 9, 4417-4423.
33. Hauber, J., Perkins, A., Heimer, E., and Cullen, B. (1987). Trans-activation of human immunodeficiency virus gene expression is mediated by nuclear events. Proc. Natl. Acad. Sci. USA 84, 6364-6368.
34. Hauber, J., Malim, M., and Cullen, B. (1989). Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein. J. Virol. 63, 1181-1187.
35. Helland, D. E., Welles, J. L., Caputo, A., and Haseltine, W. A. (1991). Transcellular transactivation by the human immunodeficiency virus type 1 tat protein. J. Virol. 65, 4547-4549.
36. Herrmann, C. H., and Rice, A. P. (1993). Specific interaction of the human immunodeficiency virus Tat proteins with a cellular protein kinase. Virology 197, 601-608.
37. Herrmann, C. H., and Rice, A. P. (1995). Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: Candidate for a Tat cofactor. J. Virol. 69, 1612-1620.
38. Hofman, F. M., Wright, A. D., Dohadwala, M. M., Wong-Staal, F., and Walker, S. M. (1993) Exogenous tat protein activates human endothelial cells. Blood 82, 2774-2780.
39. Howcroft, T. K., Strebel, K., Martin, M. A., and Singer, D. S. (1993). Repression of MHC class I gene promoter activity by two-exon Tat of HIV. Science 260, 1320-1322.
40. Iwamoto, G. K., Konicek, S. A., and Twigg, H. L., 3rd (1994). Modulation of accessory cell function and interleukin-6 production by the HIV-1 tat gene. Am. J. Respir. Cell Mol. Biol. 10, 580-585.
41. Jeang, K. T., Chun, R., Lin, N. H., Gatignol, A., Glabe, C. G., and Fan, H. (1993). In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor. J. Virol. 67, 6224-6233.
42. Jeang, K. T. (1995). "Human Retroviruses and AIDS 1995. A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences." Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, New Mexico.
43. Kashanchi, F., Duvall, J. F., and Brady, J. N. (1992). Electroporation of viral transactivator proteins into lymphocyte suspension cells. Nucleic Acids Res. 20, 4673-4674.
44. Kashanchi, F., Piras, G., Radonovich, M. F., Duvall, J. F., Fattaey, A., Chiang, C.-M., Roeder, R. G., and Brady, J. N. (1994). Direct interaction of human TFIID with the HIV-1 transactivator Tat. Nature 367, 295-299.
45. Keen, N. J., Gait, M. J., and Karn, J. (1996). Human immunodeficiency virus type 1 Tat is an integral component of the activated transcription-elongation complex. Proc. Natl. Acad. Sci. USA 93, 2505-2510.
46. Klaver, B., and Berkhout, B. (1994a). Evolution of a disrupted TAR RNA hairpin structure in the HIV-1 virus. EMBO J. 13, 2650-2659.
47. Klaver, B., and Berkhout, B. (1994b). Comparison of 5′ and 3′ long terminal repeat promoter function in human immunodeficiency virus. J. Virol. 68, 3830-3840.
48. Koken, S. E. C., van Wamel, J., and Berkhout, B. (1994). A sensitive promoter assay based on the transcriptional activator Tat of the HIV-1 virus. Gene 144, 243-247.
49. Krone, W. J., Debouck, C., Epstein, L. G., Heutink, P., Meloen, R., and Goudsmit, J. (1988). Natural antibodies to HIV-1 Tat epitopes and expression of HIV-1 genes in vivo. J. Med. Virol. 26, 261-270.
50. Lotz, M., Clark-Lewis, I., and Ganu, V. (1994). HIV-1 transactivator protein Tat induces proliferation and TGF beta expression in human articular chondrocytes. J. Cell Biol. 124, 365-371.
51. Luciw, P. (1996). "Virology" (B. N. Fields, D. M. Knipe, and P. M. Howley, Eds.), 3rd ed. Lippincott-Raven, Philadelphia/New York.
52. Mann, D. A., and Frankel, A. D. (1991). Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J. 10, 1733-1739.
53. Marcuzzi, A., Lowy, I., and Weinberger, O. K. (1992a). Transcellular activation of the Human Immunodeficiency Virus type 1 long terminal repeat in T lymphocytes requires CD4-gp120 binding. J. Virol. 66, 4536-4539.
54. Marcuzzi, A., Weinberger, J., and Weinberger, O. K. (1992b). Transcellular activation of the Human Immunodeficiency Virus type 1 long terminal repeat in cocultured lymphocytes. J. Virol. 66, 4228-4232.
55. Mavankal, G., Ignatius Ou, S. H., Oliver, H., Sigman, D., and Gaynor, R. B. (1996). Human immunodeficiency virus type 1 and 2 Tat proteins specifically interact with RNA polymerase II. Proc. Natl. Acad. Sci. USA 93, 2089-2094.
56. Nabell, L. M., Raja, R. H., Sayeski, P. P., Paterson, A. J., and Kudlow, J. E. (1994). Human immunodeficiency virus 1 Tat stimulates transcription of the transforming growth factor alpha gene in an epidermal growth factor-dependent manner. Cell Growth Diff. 5, 87-93.
57. ELI. Virology 185, 661 -672.
58. Purvis, S. R., Georges, D. L., Williams, T. M., and Lederman, M. M. (1992). Suppression of interleukin-2 and interleukin-2 receptor expression in Jurkat cells stably expressing the human immunodeficiency virus Tat protein. Cell lmmunol. 144, 32-42.
59. Re, M. C., Furlini, G., Vignoli, M., Ramazzotti, E., Roderigo, G., De Rosa, V., Zauli, Lolli, S., Capitani, S., and La Placa, M. (1995). Effect of antibody to HIV-1 Tat protein on viral replication in vitro and progression of HIV-1 disease in vivo. J. Acquir. Immune. Defic. Syndr. 10, 408-416.
60. Reiss, P., de Wolf, F., Kuiken, C. L., de Ronde, A., Dekker, J., Boucher, C. A., Debouck, C., Lange, J. M., and Goudsmit, J. (1991). Contribution of antibody response to recombinant HIV-1 gene-encoded products nef, rev, tat, and protease in predicting development of AIDS in HIV-1-infected individuals. J. Acquir. Immune. Defic. Syndr. 4, 165-172.
61. Roy, S., Delling, U., Chen, C. H., Rosen, C. A., and Sonenberg, N. (1990). A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation. Genes Dev. 4, 1365-1373.
62. Ruben, S., Perkins, A., Purcell, R., Joung, K., Sia, R., Burghoff, R., Haseltine, W., and Rosen, C. (1989). Structural and functional analysis of human immunodeficiency virus tat protein. J. Virol. 63, 1-8.
63. Sastry, K. J., Reddy, H. R., Pandita, R., Totpal, K., and Aggarwal, B. B. (1990). HIV-1 tat gene induces tumor necrosis factor-beta (lymphotoxin) in a human B-lymphoblastoid cell line. J. Biol. Chem. 265, 20091-20093.
64. Scala, G., Ruocco, M. R. Ambrosino, C., Mallardo, M., Giordano, V., Baldassarre, F., Dragonetti, E., Quinto, I., and Venuta, S. (1994). The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein. J. Exp. Med. 179, 961-971.
65. Schwartz, M. A., Schaller, M. D., and Ginsberg, M. H. (1995). Integrins: Emerging paradigms of signal transduction. Annu. Rev. Cell Dev. Biol. 11, 549-599.
66. Seed, B., and Sheen, J. Y. (1988). A simple phase-extraction assay for chloramphenicol acyltransferase activity. Gene 67, 271-277.
67. Sheline, C. T., Milocco, L. H., and Jones, K. A. (1991). Two distinct nuclear transcription factors recognize loop and bulge residues of the HIV-1 TAR RNA hairpin. Genes Dev. 5, 2508-2520.
68. Steinaa, L., Sorensen, A. M., Nielsen, J. O., and Hansen, J. E. (1994). Antibody to HIV-1 Tat protein inhibits the replication of virus in culture. Arch. Virol. 139, 263-271.
69. Taylor, J. P., Pomerantz, R., Bagasra, O., Chowdhury, M., Rappaport, J., Khalili, K., and Amini, S. (1992). TAR-independent transactivation by Tat in cells derived from the CNS: A novel mechanism of HIV-1 gene regulation. EMBO J. 11, 3395-3403.
70. Verhoef, K., Koken, S. E. C., and Berkhout, B. (1993). Electroporation of the HIV Tat trans-activator protein into cells. Anal. Biochem. 210, 210-214.
71. Veschambre, P., Simard, P., and Jalinot, P. (1995). Evidence for functional interaction between the HIV-1 Tat transactivator and the TATA box binding protein in vivo. J Mol. Biol. 250, 169-180.
72. Weeks, B. S., Desai, K., Loewenstein, P.M., Klotman, M. E., Klotman, P. E., Green, M., and Kleinman, H. K. (1993). Identification of a novel cell attachment domain in the HIV-1 Tat protein and its 90-kDa cell surface binding protein. J. Biol. Chem. 268, 5279-5284.
73. Weeks, K. M., and Crothers, D. M. (1991). RNA recognition by Tat-derived peptides: Interaction in the major groove? Cell 66, 577-588.
74. Westendorp, M. O., Shatrov, V. A., Schulze-Osthoff, K., Frank, R., Kraft, M., Los, M., Krammer, P. H., Droge, W., and Lehmann, V. (1995). HIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox state. EMBO J. 14, 546-554.
75. Wu, F., Garcia, J., Sigman, D., and Gaynor, R. (1991). Tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185. Genes Dev. 5, 2128-2140.
76. Wu-Baer, F., Sigman, D., and Gaynor, R. B. (1995). Specific binding of RNA polymerase II to the human immunodeficiency virus transactivating region RNA is regulated by cellular cofactors and Tat. Proc. Natl. Acad. Sci. USA 92, 7153-7157.
77. Wu-Baer, F., Lane, W. S., and Gaynor, R. B. (1996). Identification of a group of cellular cofactors that stimulate the binding of RNA polymerase II and TRP-185 to human immunodeficiency virus 1 TAR RNA. J. Biol. Chem. 271, 4201-4208.
78. Zauli, G., Furlini, G., Re, M. C., Milani, D., Capitani, S., and La Placa, M. (1993a). Human immunodeficiency virus type 1 (HIV-1) tat-protein stimulates the production of interleukin-6 (IL-6) by peripheral blood monocytes. Microbiologica 16, 115-120.
79. Zauli, G., Gibellini, D., Milani, D., Mazzoni, M., Borgatti, P., La Placa, M., and Capitani, S. (1993b). Human immunodeficiency virus type 1 Tat protein protects lymphoid, epithelial, and neuronal cell lines from death by apoptosis. Cancer Res. 53, 4481-4485.
80. Zauli, G., La Placa, M., Vignoli, M., Carla Re, M., Gibellini, D., Furlini, G., Milani, D., Marchisio, M., Mazzoni, M., and Capitani, S. (1995). An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently tat-transfected cells and required for optimal HIV-1 LTR transactivating activity. J. Acquir. Immune. Defic. Syndr. Human Retrovirol. 10, 306-316.
81. Zhou, Q., and Sharp, P.A. (1995). Novel mechanism and factor for regulation by HIV-1 Tat. EMBO J. 14, 321-328.